# Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV

> **NCT00842634** · PHASE1 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 12 (actual)

## Conditions studied

- HIV
- HIV Infections

## Interventions

- **BIOLOGICAL:** ZFN modified T cells
- **OTHER:** Structured Treatment Interruption

## Key facts

- **NCT ID:** NCT00842634
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00842634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00842634, "Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00842634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*